Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
Título
Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
Autor
Michel Brazier, Aurélien Mary, Aurélien Mary, Lucie Hénaut, Jean-Luc Schmit, Jean-Luc Schmit, Jean-Philippe Lanoix, Jean-Philippe Lanoix, Michel Brazier
Fecha
2020
Materia
covid-19, SARS-CoV-2, Hydroxychloroquine, type I interferon, azithromycin
Identificador
10.3389/fpubh.2020.00185
Fuente
Epidemiology and Health
Editor
Korean Society of Epidemiology
Cobertura
Public aspects of medicine
Archivos
Colección
Citación
Michel Brazier, Aurélien Mary, Aurélien Mary, Lucie Hénaut, Jean-Luc Schmit, Jean-Luc Schmit, Jean-Philippe Lanoix, Jean-Philippe Lanoix, Michel Brazier, “Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/7206.
Position: 18607 (16 views)